Genomma Lab InternacionalB de CV (MEX:LABB) Net Issuance of Preferred Stock : MXN0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Genomma Lab InternacionalB de CV's net issuance of preferred for the three months ended in Sep. 2024 was MXN0 Mil. The number is 0, which means that Genomma Lab InternacionalB de CV has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Genomma Lab InternacionalB de CV's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2024 was MXN0 Mil.

Genomma Lab InternacionalB de CV Net Issuance of Preferred Stock Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Net Issuance of Preferred Stock Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Genomma Lab InternacionalB de CV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Genomma Lab InternacionalB de CV Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

Genomma Lab InternacionalB de CV Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Net Issuance of Preferred Stock

Traded in Other Exchanges

GNMLF:USA GEKA:Germany

Address

Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines